证券日报网讯港通医疗10月21日在互动平台回答投资者提问时表示，公司截至2025年10月20日股东总户 数为7545户。 （文章来源：证券日报） ...

Group 1 - The core business of the company includes providing medical gas systems and clean operating room solutions, with revenue composition being 55.69% from clean equipment and systems, 37.30% from medical gas equipment and systems, 4.06% from medical device sales, 2.81% from operation and maintenance services, and 0.14% from other sources [2] - As of October 10, the number of shareholders for the company increased by 0.75% to 7,562, while the average circulating shares per person decreased by 0.74% to 8,336 shares [2] - For the first half of 2025, the company reported a revenue of 265 million yuan, a year-on-year decrease of 39.29%, and a net profit attributable to the parent company of -8.4044 million yuan, a year-on-year decrease of 154.53% [2] Group 2 - The company has distributed a total of 48.9973 million yuan in dividends since its A-share listing [3] Group 3 - On October 16, the company's stock price fell by 0.66%, with a trading volume of 11.0857 million yuan [1] - The financing buy-in amount on the same day was 493,400 yuan, while the financing repayment was 805,500 yuan, resulting in a net financing buy of -312,100 yuan [1] - The total financing and securities lending balance as of October 16 was 38.7272 million yuan, with the financing balance accounting for 2.62% of the circulating market value, indicating a relatively high level compared to the past year [1]

Group 1 - The core business of Sichuan Portong Medical Equipment Group Co., Ltd. includes providing overall solutions for medical institutions, focusing on medical gas systems and clean operating rooms [2] - As of October 10, the number of shareholders for Portong Medical increased by 0.75% to 7,562, while the average circulating shares per person decreased by 0.74% to 8,336 shares [2] - For the first half of 2025, Portong Medical reported a revenue of 265 million yuan, a year-on-year decrease of 39.29%, and a net profit attributable to the parent company of -8.4044 million yuan, a year-on-year decrease of 154.53% [2] Group 2 - On October 15, Portong Medical's stock price fell by 0.14%, with a trading volume of 18.3229 million yuan [1] - The financing data on October 15 showed a financing buy-in of 2.0963 million yuan and a financing repayment of 3.4550 million yuan, resulting in a net financing buy of -1.3587 million yuan [1] - The total balance of margin trading for Portong Medical as of October 15 was 39.0393 million yuan, with the financing balance accounting for 2.63% of the circulating market value, indicating a high level compared to the past year [1]

证券日报网讯港通医疗（301515）10月14日在互动平台回答投资者提问时表示，公司截至2025年10月10 日股东总户数为7562户。 ...

关于持股5%以上股东股权结构发生变动的进展公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 四川港通医疗设备集团股份有限公司（以下简称"公司"）于2025年9月25 日披露了《关于持股5%以上股东股权结构拟发生变动的公告》（公告编号： 2025-056），公司收到持股5%以上股东GT South(HongKong) Limited（以下简称 "香港GT"）的通知，其上层股东GT North(Cayman)Ltd.,（以下简称"开曼GT"） 的上层股东Ares Corporate Opportunities Fund Asia,L.P.（以下简称"Ares"） 与Ever Thrive Global Limited（以下简称"Ever Thrive"）共同签署了《股 权收购协议》，Ever Thrive拟受让Ares持有的开曼GT100%股权。股权转让完成 后，Ever Thrive变更为开曼GT唯一股东，Ever Thrive通过开曼GT和香港GT间接 持有公司11.50%股权（Ever Thrive持有开曼GT100%股权；开曼GT持有香港GT100% ...

Market Overview - The Shanghai Composite Index closed at 3889.50 points, below the five-day moving average, with a decline of 0.19% [1] - The total trading volume of A-shares reached 237.42 billion yuan [1] Stocks Performance - A total of 284 A-shares broke through the five-day moving average today [1] - Stocks with significant deviation rates include: - Galaxy Magnetic Materials (14.40%) - Jiangfeng Electronics (9.00%) - Jinyinhai (8.31%) [1] Top Stocks by Deviation Rate - The following stocks had the highest deviation rates from the five-day moving average: - Galaxy Magnetic Materials: 20.01% increase, turnover rate of 16.89%, latest price at 38.74 yuan [1] - Jiangfeng Electronics: 14.54% increase, turnover rate of 20.46%, latest price at 114.52 yuan [1] - Jinyinhai: 12.35% increase, turnover rate of 15.45%, latest price at 37.67 yuan [1] - Other notable stocks include: - Tongyuan Environment: 11.16% increase, latest price at 22.12 yuan [1] - Boshang Optoelectronics: 12.12% increase, latest price at 132.30 yuan [1]

Core Points - The company, 港通医疗 (301515.SZ), announced a share buyback program, repurchasing a total of 2,858,786 shares, which represents 2.86% of its total share capital [1] - The highest transaction price during the buyback was 19.68 CNY per share, while the lowest was 16.57 CNY per share [1] - The total amount spent on the buyback was 53,046,196.79 CNY, excluding transaction fees [1] - The buyback complies with relevant laws and regulations as well as the company's established share repurchase plan [1]

证券代码：301515 证券简称：港通医疗 公告编号：2025-057 四川港通医疗设备集团股份有限公司 关于2024年第二次回购公司股份进展的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 四川港通医疗设备集团股份有限公司（以下简称"公司"）于 2024 年 11 月 4 日召开第四届董事会第十七次会议和第四届监事会第十七次会议，审议通过 《关于 2024 年第二次回购公司股份方案的议案》，公司拟使用不低于人民币 5,000 万元（含）且不超过人民币 10,000 万元（含）的自有资金和专项回购贷款 资金以集中竞价交易的方式回购公司已发行的人民币普通股（A 股）股票，回购 价格不超过人民币 28.49 元/股（含），回购的股份将用于实施员工持股计划或 股权激励。本次回购股份的实施期限为自公司董事会审议通过本次回购股份方案 之日起不超过 12 个月。具体回购股份的数量以回购期满或回购完毕时公司实际 回购的股份数量为准。 公司于 2024 年 11 月 8 日召开 2024 年第一次临时股东会，审议通过《关于 公司 2024 年前三季度利润分配预案的议案》 ...

南财智讯9月25日电，港通医疗公告，AresCorporateOpportunitiesFundAsia,L.P.将其持有的开曼GT100% 股权转让给EverThrive，导致Ares不再控制公司5%以上股东香港GT。此次权益变动前，Ares通过开曼 GT和香港GT间接持有公司11.50%股权；变动后，Ares不再持有公司股份。EverThrive通过开曼GT和香 港GT间接持有公司11.50%股权。Ares在未来12个月内无增持或减持计划。 ...

证券代码：301515 证券简称：港通医疗 公告编号：2025-056 2025年9月24日，四川港通医疗设备集团股份有限公司（以下简称"公司"、 "港通医疗"）收到持股5%以上股东GT South (Hong Kong) Limited（以下简称 "香港GT"）的通知，其上层股东GT North (Cayman) Ltd.，（以下简称"开曼 GT"）的上层股东Ares Corporate Oppotunities Fund Asia, L.P.（以下简称 "Ares"）与Ever Thrive Global Limited（以下简称"Ever Thrive"）共同 签署了《股权收购协议》，Ever Thrive受让Ares持有的开曼GT100%股权。Ares、 Ever Thrive已履行权益变动报告义务，具体内容详见同日披露于巨潮资讯网 （http://www.cninfo.com.cn）的《简式权益变动报告书》（Ares）、《简式权 益变动报告书》（Ever Thrive）。 本次股权转让前，Ares通过开曼GT和香港GT间接持有公司11.50%股权（Ares 持有开曼GT 100%股权；开曼GT持有香 ...